OVID: ovidrx.com Narxning foydaga nisbati

Ovid Rx (OVID) brendining ramzi va logotipi

Ovid Therapeutics Inc. (OVID) aksiyalarining narxlar tarixi PE koeffitsiyenti dinamikasini aks ettiradi, u hozirda -10.90 darajasida turibdi. Kamyob kasalliklar dori vositalari nishasida kirish to'siqlarining yuqoriligi va ulkan tadqiqot xarajatlari raqobatni cheklaydi. Ovid Therapeutics Inc. (OVID) yangi molekulalarni sinovdan o'tkazishni tezlashtirish uchun biofarmatsevtika gigantlari bilan ittifoqlarga tayanadi. Bolalar epilepsiyasi terapiyasi uchun patent himoyasi va uzoq muddatli R&D shartnomalari barqaror himoya mexanizmini ta'minlaydi va moliyaviy risklarni yumshatadi.

Ovid Therapeutics (OVID) P/E multiplikatori: 04.07.2022 - 16.11.2026 davri uchun

Ovid Therapeutics Inc (OVID) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning jamlanma tahlili:Ovid Therapeutics - OVID
Ovid Therapeutics yetakchi tovari

Ovid Therapeutics Inc. (OVID) kompaniyasining barqarorligi markaziy nerv tizimi (CNS) dori vositalari uchun o'tkazilayotgan klinik sinovlarning muvaffaqiyati va tadqiqot va ishlanmalar (R&D) uchun likvidlik mavjudligi bilan ta'minlanmoqda. P/E koeffitsiyentini tahlil qilish orqali investor bozor kapitalizatsiyasi va sof foyda o'rtasidagi bog'liqlikni ko'rishi mumkin, bu esa kompaniyaning kelgusidagi muvaffaqiyatlari uchun to'lanadigan premium miqdorini belgilaydi. Ushbu ko'rsatkich investitsiyalarning qoplash muddatini o'lchaydi va fundamental qiymatni spekulyativ pufakdan ajratishga yordam beradi.

Muhim raqobatchilar

Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|XENE - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Viking Therapeutics Inc VKTX|Supernus Pharma (SUPN) - Narxning foydaga nisbati|CPRX (Catalyst Pharmaceuticals) - Narxning foydaga nisbati|DNLI (denalitherapeutics.com) - P/E multiplikatori|Narx-foyda multiplikatori HRMY (Harmony Biosciences Holdings, Inc.)|P/E multiplikatori BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Kapitalizatsiyaning sof foydaga nisbati|anavex.com - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CBLL (CeriBell, Inc.)|PRTA: P/E multiplikatori|Narx-foyda multiplikatori ALEC|ANNX (Annexon Biosciences Inc.) - P/E multiplikatori|omeros.com - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Neurogene (NGNE)|Biznesning o‘zini qoplash muddati AC Immune SA|P/E multiplikatori VYGR (voyagertherapeutics.com)|P/E multiplikatori Neumora NMRA|Scilex Holding - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tevogen Bio Inc.|Alpha Cognition (ACOG) - Narxning foydaga nisbati|cogrx.com (CGTX) - P/E multiplikatori|Narxning foydaga nisbati Inhibikase Therapeutics|Cassava (SAVA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Assertio Therapeutics (ASRT)|Biznesning o‘zini qoplash muddati Coya|Vistagen - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - P/E multiplikatori|Biznesning o‘zini qoplash muddati alteritytherapeutics.com ATHE|CLNN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati PepGen Corp (PEPG)|Narxning foydaga nisbati Jupiter Neurosciences, Inc.|RLMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ANVS|Narx-foyda koeffitsiyenti Grace Tx GRCE|Narxning foydaga nisbati Firefly Neuroscience, Inc AIFF|KLTO: Narx-foyda multiplikatori|NRSN - Narxning foydaga nisbati|RVPH: Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narx-foyda koeffitsiyenti|NeurAxis Inc. (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical|Passage Bio, Inc. - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti NEUP (Neuphoria)|NERV - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ATHA (athira.com)|P/E multiplikatori Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (Protagenic Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pasithea (KTTA)|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori